| Application no. and date | 21701890.2 (espacenet) (Federated) (European Patent Register), 20210108 | | Patent/reg. no. and date | DK/EP 4087875, 20240828 | | Publication date | 20221116 | | Priority no. and date | US 202062958543 P, 20200108, US 202062960647 P, 20200113 | | EP pub. no. and date |
EP 4087875 20221116 | | Effective date | | | Applicant/owner | Argenx BV, Industriepark Zwijnaarde 7
9052 Gent, BE | | Applicant ref. no. | 6.2410.001 | | Inventor | VERHEESEN, Peter, c/o Industriepark Zwijnaarde 7
9052 Gent, BE,
DUPUY, Patrick, c/o Industriepark Zwijnaarde 7
9052 Gent, BE | | Representative | Holme Patent A/S, Valbygårdsvej 33, 1, 2500 Valby, DK | | Opponent | | | IPC Class | A61K 31/573 (2006.01) , A61K 39/395 (2006.01) , A61P 17/00 (2006.01) , A61P 37/06 (2006.01) , C07K 16/18 (2006.01) , C07K 16/28 (2006.01) | | Title | Antagonister af human neonatal Fc-receptor (FcRn) til behandling af pemphigus-sygdomme | | Int. application no. | EP2021050275 | | Int. publication no. | WO2021140202 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
